Replies to post #373 on Questcor Pharmaceuticals, Inc. (QCOR)

[protagonist12]

Yeah strange AH dip on blowout earnings. A similar thing happened after 2012 Q4 earnings report. QCOR blew away analysts EPS forcasts by .30 a share and yet the thing traded sideways for months.

You have to wonder why this stock has been in a holding pattern for 6 over months, but I guess there are still questions as to whether or not Achtar will be covered by major policies such as Aetna. Gee I wonder if Andrew Left and Citron Research is still shorting this.